Effect of Prognostic Nutrition Index in Gastric or Gastro-oesophageal Junction Cancer Patients Undergoing Nivolumab Monotherapy

Conclusion: PNI could be a useful prognostic factor in GC or GOC patients undergoing nivolumab monotherapy.

Source: In Vivo - January 5, 2021 Category: Research Authors: WATANABE, H., YAMADA, T., KOMORI, K., HARA, K., KANO, K., TAKAHASHI, K., KUMAZU, Y., FUJIKAWA, H., NUMATA, M., AOYAMA, T., TAMAGAWA, H., INOKUCHI, Y., MACHIDA, N., SHIOZAWA, M., YUKAWA, N., MORINAGA, S., RINO, Y., MASUDA, M., OGATA, T., OSHIMA, T. Tags: Clinical Studies Source Type: research